FDA Inspection 1059746 — Biomat USA Inc

Biomat USA Inc — FEI 1643030

The FDA completed an inspection of Biomat USA Inc on July 20, 2018 in Las Cruces, NM. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 20, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Las Cruces, NM (United States)

Citations

IDCFRDescription
4121 CFR 606.40(a)(1)Provide space for examination